US FDA puts clinical hold on Kezar Life Sciences' lupus treatment trial

Kezar Life Sciences

04/10/2024 22:08

Oct 4 (Reuters) - The U.S. Food and Drug Administration
has placed a clinical hold on Kezar Life Sciences'  KZR.O  trial
of experimental drug for lupus, the company said on Friday.     

 (Reporting by Mariam Sunny in Bengaluru; Editing by Mohammed
Safi Shamsi)
 ((Mariam.ESunny@thomsonreuters.com;))